A novel and cost-effective model to screen and treat cervical cancer and precancers at the point of care
BackgroundCervical cancer has a high incidence to high mortality rate and poses an important global burden that disproportionately affects women in underdeveloped areas of the world.The World Health Organization has proposed a new and ambitious policy that aims to reduce the number of deaths from cervical cancer by 62.6 million over the next 70 yea